📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody. (2020)

First Author: Huda S

Attributed to: Disease mechanisms and therapy for inherited disorders of the neuromuscular synapse. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1212/nxi.0000000000000645

PubMed Identifier: 31831571

Publication URI: http://europepmc.org/abstract/MED/31831571

Type: Journal Article/Review

Volume: 7

Parent Publication: Neurology(R) neuroimmunology & neuroinflammation

Issue: 1

ISSN: 2332-7812